Search bioRxiv⌕ Search

Biology subjects

Schwarzkopf, L.

Publications and source records attributed to Schwarzkopf, L..

2 recordsLinked to original sources

Automated acoustic classifiers provide insights into calling patterns of cicadas in tropical Australia

Insects are a key group in ecosystems and economics, but are increasingly under threat, making ongoing monitoring essential to preserving them. Traditional monitoring approaches are time consuming, among other limitations. Automated acoustic recognition can be a good solution for monitoring arboreal, soniferous insects, such as cicadas, and the acoustic biology of cicadas in Australia is understudied, especially using automated methods. To evaluate the applicability of automated approaches for detecting cicadas, we used the deep-learning acoustic model BirdNET (v2.4) to perform embedding searches for Cystosoma schmeltzi (lesser bladder), Illyria burkei (eastern rattler), Macrotristria intersecta (corroboree cicada), Thopha sessiliba (northern double-drummer), and Pauropsalta opaca (fairy dust squawker), using audio recorded by Passive Acoustic Monitoring over 15-months at 18 sites in north Queensland. All classifiers achieved high area under the precision-recall curve (AUPRC) ranging from 0.753 to 0.982. We used a precision-prioritised threshold ([≥] 0.85) to constrain the false positive rate while retaining adequate outputs, which were consistent with the documented species ecology and life history. This approach was readily applicable to the Cicadidae, offering a scalable solution for biodiversity monitoring in complex acoustic environments.

ecology↗

KLF4 acts as a tumor suppressor in human B-cells and patients’ B-cell leukemias growing in mice

Clinic-close methods are not available that prioritize and validate potential therapeutic targets in individual tumors from the vast bulk of descriptive expression data. We developed a novel technique to express transgenes in established patient-derived xenograft (PDX) models in vivo to fill this gap. With this technique at hand, we analyzed the role of transcription factor Kruppel-like factor 4 (KLF4) in B-cell acute lymphoblastic leukemia (B-ALL) PDX models at different disease stages. In competitive pre-clinical in vivo trials, we found that re-expression of wild type KLF4 reduced leukemia load in PDX models of B-ALL, with strongest effects after conventional chemotherapy at minimal residual disease (MRD). A non-functional KLF4 mutant had no effect in this model. Re-expressing KLF4 sensitized tumor cells in the PDX model towards systemic chemotherapy in vivo. Of major translational relevance, Azacitidine upregulated KLF4 levels in the PDX model and a KLF4 knockout reduced Azacitidine-induced cell death, suggesting that Azacitidine can regulate KLF4 re-expression. These results support applying Azacitidine in patients with B-ALL to regulated KLF4 as a therapeutic option. Taken together, our novel technique allows studying the function of dysregulated genes in a highly clinic-related, translational context and testing clinically applicable drugs in a relevant pre-clinical model.

cancer biology↗